Article citationsMore >>

Marti CO, Fellay B, Bürgin-Wolff A, Magnin J-L, Baehler P. Evaluation of a DGP Point-of-care Test for Celiac Disease in a Pediatric Population. International Journal of Celiac Disease. 2015;3(1):7-11.

has been cited by the following article:

Article

Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease

1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran


International Journal of Celiac Disease. 2017, Vol. 5 No. 3, 95-96
DOI: 10.12691/ijcd-5-3-6
Copyright © 2017 Science and Education Publishing

Cite this paper:
Mohammad Rostami Nejad. Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease. International Journal of Celiac Disease. 2017; 5(3):95-96. doi: 10.12691/ijcd-5-3-6.

Correspondence to: Mohammad  Rostami Nejad, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: m.rostamii@gmail.com

Abstract

Antibodies to deamidated gliadin peptides (DGP-AGA) have newly been presented into the extensive variety of serologic examinations for celiac disease (CD). In compare with the modern AGA, DGP-AGA indicated a higher sensitivity and specificity for CD and simply identified by ELISA kits. Nevertheless, even though the very favorable outcomes, DGP-AGA are not yet regularly used in the serologic checkup for CD. An antibody approach could initiate development in the diagnostic precision of serology for CD screening.

Keywords